|
Sunil Chada, PhD
Introgen Therapeutics, Inc.
Robert Charnas, PhD
Amgen, Inc.
Matt Coffey, PhD
Oncolytics Biotech Inc.
Laurence Elias, MD
Geron Corporation
Marta Fields
Amgen, Inc.
Lothar H. Finke, MD
ARGOS Therapeutics
Ying Huang, PhD
Food and Drug Administration, CBER
Rachel W. Humphrey, MD
Bristol-Myers Squibb Company
Elizabeth M. Jaffee, MD
Johns Hopkins University
Susan Jerian, MD
OncoRD, Inc.
Carl H. June, MD
University of Pennsylvania
Patrica Keegan, MD
Food and Drug Administration
Samir Khleif, MD
National Cancer Institute, CCR
John M. Kirkwood, MD
University of Pittsburgh
Frederic Lehmann, MD
GlaxoSmithKline Biologicals s.a.
|
Michael T. Lotze, MD
University of Pittsburgh Cancer Institute
Crystal Mackall, MD
National Cancer Institute, Pediatric Oncology
Andrew J. McDougal, PhD, DABT
Food and Drug Administration, CDER
Jeffrey Miller, MD
University of Minnesota
C. Randal Mills, PhD
Osiris Therapeutics, Inc.
Christopher Moulding
USC Stevens Institute for Innovation
David Parkinson, MD
Nodality, Inc.
Raj Puri, MD, PhD
Food and Drug Administration, CBER
Nicholas P. Restifo, MD
National Cancer Institute
Michel Sadelain, MD, PhD
Memorial Sloan-Kettering Cancer Center
Mercedes Serabian, MS, DABT
Food and Drug Administration, CBER
Ken Takeshita, MD
Celgene
Robert H. Vonderheide, MD, D.Phil
University of Pennsylvania, Abramson Family Cancer Rsch. Inst.
Anthony R. Welch, PhD
National Cancer Institute
Robert J. Zimmerman, SD
Zimmerman Consulting
|
|